Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Equity Compensation Plans	Scilex Holding Company	Common Stock	Common Stock Equity Compensation Plans	Treasury Stock	Additional Paid-in Capital	Additional Paid-in Capital Equity Compensation Plans	Additional Paid-in Capital Scilex Holding Company	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Noncontrolling Interest	Noncontrolling Interest Scilex Holding Company
Balance at Dec. 31, 2021	$ 78,129			$ 32		$ (49,464)	$ 1,513,758			$ 1,026	$ (1,386,604)	$ (619)
Balance, shares (in shares) at Dec. 31, 2021				314,573		7,568
Issuance of common stock, net	164,437	$ 132		$ 6			164,431	$ 132
Issuance of common stock, net (in shares)				58,875	438
Acquisitions consideration paid in equity	4,435						4,435
Acquisitions consideration paid in equity (in shares)				1,282
Stock-based compensation	20,854						20,854
Foreign currency translation adjustment	(1,249)									(1,249)
Net loss	(40,540)										(40,815)	275
Balance at Mar. 31, 2022	226,198			$ 38		$ (49,464)	1,703,610			(223)	(1,427,419)	(344)
Balance, shares (in shares) at Mar. 31, 2022				375,168		7,568
Balance at Dec. 31, 2021	78,129			$ 32		$ (49,464)	1,513,758			1,026	(1,386,604)	(619)
Balance, shares (in shares) at Dec. 31, 2021				314,573		7,568
Foreign currency translation adjustment	837
Net loss	(260,017)
Balance at Jun. 30, 2022	135,763			$ 18		$ (49,464)	1,826,810			837	(1,646,178)	3,740
Balance, shares (in shares) at Jun. 30, 2022				436,419		7,568
Balance at Mar. 31, 2022	226,198			$ 38		$ (49,464)	1,703,610			(223)	(1,427,419)	(344)
Balance, shares (in shares) at Mar. 31, 2022				375,168		7,568
Issuance of common stock, net	104,169	$ 668		$ 6			104,163	$ 668
Issuance of common stock, net (in shares)				60,707	544
Stock-based compensation	18,369						18,369
Changes to noncontrolling interests	4,776			$ (26)								4,802
Foreign currency translation adjustment	1,060									1,060
Net loss	(219,477)										(218,759)	(718)
Balance at Jun. 30, 2022	135,763			$ 18		$ (49,464)	1,826,810			837	(1,646,178)	3,740
Balance, shares (in shares) at Jun. 30, 2022				436,419		7,568
Balance at Dec. 31, 2022	(21,669)			$ 52		$ (49,464)	1,988,753			1,501	(1,959,447)	(3,064)
Balance, shares (in shares) at Dec. 31, 2022				522,817		7,568
Issuance of common stock, net	28,369		$ 1,870	$ 3			28,366						$ 1,870
Issuance of common stock, net (in shares)				28,336
Other acquisitions, license agreements and investments paid in equity (in shares)				128
Stock-based compensation	18,311						18,311
Scilex Holding dividend									$ (14,282)				14,282
Foreign currency translation adjustment	325									325
Net loss	(154,626)										(139,616)	(15,010)
Balance at Mar. 31, 2023	(127,420)			$ 55		$ (49,464)	2,021,148			1,826	(2,099,063)	(1,922)
Balance, shares (in shares) at Mar. 31, 2023				551,281		7,568
Balance at Dec. 31, 2022	(21,669)			$ 52		$ (49,464)	1,988,753			1,501	(1,959,447)	(3,064)
Balance, shares (in shares) at Dec. 31, 2022				522,817		7,568
Foreign currency translation adjustment	739
Net loss	(263,063)
Balance at Jun. 30, 2023	(197,956)			$ 55		$ (49,464)	2,036,331			2,240	(2,194,275)	7,157
Balance, shares (in shares) at Jun. 30, 2023				551,281		7,568
Balance at Mar. 31, 2023	(127,420)			$ 55		$ (49,464)	2,021,148			1,826	(2,099,063)	(1,922)
Balance, shares (in shares) at Mar. 31, 2023				551,281		7,568
Issuance of common stock, net			$ 22,403										$ 22,403
Stock-based compensation	15,183						15,183
Foreign currency translation adjustment	414									414
Net loss	(108,536)										(95,212)	(13,324)
Balance at Jun. 30, 2023	$ (197,956)			$ 55		$ (49,464)	$ 2,036,331			$ 2,240	$ (2,194,275)	$ 7,157
Balance, shares (in shares) at Jun. 30, 2023				551,281		7,568